Torrent Pharmaceuticals Limited has announced the issuance of 30,000 listed, rated, transferable, rupee-denominated Commercial Papers (CPs) with a face value of ₹5,00,000 each. The total aggregate amount raised through this issuance is ₹1,500 Crores.

The Commercial Papers are proposed to be listed on the National Stock Exchange of India (NSE). The instrument has a tenure of 337 days, with the allotment date being 19th January 2026 and the maturity/redemption date set for 22nd December 2026.

The coupon or interest rate for this issuance is 7.20%, with interest paid upfront and the principal payable on maturity. The Commercial Papers are unsecured, and there are no special rights or privileges attached to them. The company has also confirmed that there are no delays or defaults in payment of interest or principal.